Streetbeat News

Earnings

FSM

Fortuna Silver Mines Inc. (NYSE:FSM) reported strong Q1 2024 gold and gold equivalent production, with gold production up 49% Y/Y and gold equivalent ounces up 20% Y/Y, despite a 32% Y/Y decline in silver production. The company operates mines in West Africa and Latin America, with significant production increases noted in the West Africa Region. Fortuna reiterated its FY24 production guidance for gold, silver, and gold equivalent ounces. FSM shares rose 1.91% in premarket trading.

Portfolio Pulse from Lekha Gupta

April 08, 2024 | 12:13 pm

OR

Osisko Gold Royalties Ltd (OR) announced its Q1 2024 results, including 22,259 gold equivalent ounces delivered, preliminary revenues of $60.7M from royalties and streams, and a cash margin of approximately $58.9M. The company also reported a cash position of $70.6M after repaying $43.6M on its revolving credit facility, leaving $151.9M drawn and $398.1M available, plus an uncommitted accordion of up to $200.0M.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:11 pm

AEHL

CACO

DCO

EH

LICY

In Monday's pre-market session, several industrials stocks showed significant movement. Gainers included Antelope Ent Hldgs (AEHL) with a 33.3% rise, and losers featured Caravelle Intl Gr (CACO) with a 17.4% decline. Other notable movements were seen in stocks like Ducommun (DCO), EHang Holdings (EH), and Li-Cycle Holdings (LICY), among others, with various factors such as Q4 earnings influencing the market.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 12:09 pm

NTRA

Natera announced new data from the Trifecta-Heart and DTRT-2 studies, which show the Prospera Heart test's effectiveness in detecting heart transplant rejection in both adults and children. These prospective, multi-center studies validate the clinical use of the Prospera Heart dd-cfDNA test for heart transplant recipients.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:03 pm

APLD

Applied Digital Corporation (NASDAQ:APLD) is set to release its Q3 earnings before the market opens on April 10, 2024. Analysts predict a quarterly loss of 7 cents per share with revenue expected at $51.92 million. The company's shares dropped 8.9% to $2.98 following the announcement of a definitive purchase agreement with Marathon Digital for the acquisition of its Bitcoin mining data center. Analysts from B. Riley Securities, Needham, Lake Street, and Craig-Hallum have provided varied ratings and price targets for APLD.

Portfolio Pulse from Avi Kapoor

April 08, 2024 | 12:03 pm

AMLX

Amylyx Pharma (NASDAQ:AMLX) has been the subject of diverse analyst ratings over the past three months, with a total of 6 analysts offering perspectives ranging from bullish to bearish. The average 12-month price target for AMLX has significantly declined to $10.67 from a previous average of $31.67, indicating a 66.31% decrease. Analyst actions include maintaining, lowering, and raising ratings and price targets, reflecting responses to market dynamics and company performance. Amylyx Pharma, a clinical-stage pharmaceutical company, has shown remarkable revenue growth of 395.54% as of December 31, 2023, but trails behind industry peers in the Health Care sector. The company's financial performance is highlighted by its net margin of 4.36%, ROE of 1.11%, ROA of 0.96%, and a low debt-to-equity ratio of 0.01.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 12:00 pm

GLD

SPY

U.S. stock markets ended higher on April 5th, driven by a strong jobs report, suggesting the Federal Reserve may hold off on reducing interest rates. Asian markets were mixed, with gains in Japan, Australia, and India, but declines in China. European markets rose, and gold hit a new high at $2,350. U.S. futures were slightly down in early trading.

Portfolio Pulse from Akanksha Bakshi

April 08, 2024 | 11:38 am

TSLA

Tesla Inc. (TSLA) shares are rebounding in premarket trading after a 6% drop last week due to rumors of a scrapped low-cost EV project. Despite CEO Elon Musk's denial, the stock fell 3.63% on Friday. The rebound, with shares up 1.86% to $167.96, is attributed to Musk's announcement of a robotaxi unveiling on Aug. 8, which has analysts optimistic about Tesla's full-self driving software. Gene Munster of Deepwater Asset Management supports Tesla's focus on robotaxis, predicting their deployment by 2027. Technical factors and the stock's bounce off a support level also contribute to the positive outlook, with investors eyeing the upcoming Q1 earnings report on April 23rd.

Portfolio Pulse from Shanthi Rexaline

April 08, 2024 | 11:32 am

PTN

Palatin Technologies, Inc. (NYSE:PTN) announced the presentation of topline results from its Phase 3 PL9643 MELODY-1 clinical trial for dry eye disease at the ASCRS 2024. The trial evaluated the safety and efficacy of PL9643 versus vehicle.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:31 am

PERI

Perion Network Ltd. (NASDAQ:PERI) shares plummeted premarket Monday after the company reported disappointing preliminary results for Q1 FY24 and significantly lowered its FY24 guidance. The company's revenue and adjusted EBITDA for Q1 were below consensus expectations, attributed to a decline in Search Advertising activity due to changes by Microsoft Bing. Additionally, Perion lowered its FY24 revenue and adjusted EBITDA outlook, citing challenges in Search Advertising and web video activity. Despite these setbacks, the company is focusing on expanding its Display Advertising activity and leveraging its strong cash balance for strategic acquisitions.

Portfolio Pulse from Lekha Gupta

April 08, 2024 | 11:21 am